{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:20:07Z","timestamp":1791505207691,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.carrev.2025.02.005","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T20:13:00Z","timestamp":1738959180000},"page":"98-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Outcomes of aortic stenosis in patients with cardiac amyloidosis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7912-5671","authenticated-orcid":false,"given":"Soban","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Junaid","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Newlun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Sand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anan Abu","family":"Rmilah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amman","family":"Yousaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Asim","family":"Shabbir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahbaz A.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Goldsweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.carrev.2025.02.005_bb0005","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/07853890701842988","article-title":"Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study","volume":"40","author":"Tanskanen","year":"2008","journal-title":"Ann Med"},{"issue":"5","key":"10.1016\/j.carrev.2025.02.005_bb0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.26599\/1671-5411.2023.05.006","article-title":"Cardiac amyloidosis: state-of-the-art review","volume":"20","author":"Bukhari","year":"2023","journal-title":"J Geriatr Cardiol"},{"issue":"11","key":"10.1016\/j.carrev.2025.02.005_bb0015","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jacc.2013.05.015","article-title":"Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study","volume":"62","author":"Osnabrugge","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.carrev.2025.02.005_bb0020","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJMoa1200384","article-title":"Two-year outcomes after transcatheter or surgical aortic-valve replacement","volume":"366","author":"Kodali","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.carrev.2025.02.005_bb0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10741-023-10350-1","article-title":"Valvular heart disease in patients with cardiac amyloidosis","volume":"29","author":"Aimo","year":"2024","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.carrev.2025.02.005_bb0030","doi-asserted-by":"crossref","unstructured":"Zhao L, Buxbaum JN, Reixach N. Age-related oxidative modifications of transthyretin modulate its amyloidogenicity. Biochemistry. Mar 19 2013;52(11):1913\u201326. doi:https:\/\/doi.org\/10.1021\/bi301313b.","DOI":"10.1021\/bi301313b"},{"key":"10.1016\/j.carrev.2025.02.005_bb0035","article-title":"Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis","volume":"19(1):98","author":"Cavalcante","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"issue":"2","key":"10.1016\/j.carrev.2025.02.005_bb0040","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ejhf.1974","article-title":"Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis","volume":"23","author":"Rosenblum","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.carrev.2025.02.005_bb0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jcmg.2020.07.011","article-title":"Prognostic significance of cardiac amyloidosis in patients with aortic stenosis: a systematic review and Meta-analysis","volume":"14","author":"Ricci","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2025.02.005_bb0050","article-title":"Cardiac amyloidosis and aortic stenosis: a state-of-the-art review","volume":"3(6):oead106","author":"Jaiswal","year":"2023","journal-title":"Eur Heart J Open"},{"issue":"2","key":"10.1016\/j.carrev.2025.02.005_bb0055","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","article-title":"Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis","volume":"77","author":"Nitsche","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2025.02.005_bb0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.amjcard.2023.04.003","article-title":"Transcatheter aortic valve implantation in cardiac amyloidosis and aortic stenosis","volume":"198","author":"Riley","year":"2023","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.carrev.2025.02.005_bb0065","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2217\/fca-2021-0118","article-title":"Aortic valve intervention for aortic stenosis and cardiac amyloidosis: a systematic review and meta-analysis","volume":"18","author":"de Campos","year":"2022","journal-title":"Future Cardiol"},{"key":"10.1016\/j.carrev.2025.02.005_bb0070","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 03 29 2021;372:n71. doi:https:\/\/doi.org\/10.1136\/bmj.n71.","DOI":"10.1136\/bmj.n71"},{"key":"10.1016\/j.carrev.2025.02.005_bb0075","doi-asserted-by":"crossref","unstructured":"G\u00e9n\u00e9reux P, Piazza N, Alu MC, et al. Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research. J Am Coll Cardiol. Jun 01 2021;77(21):2717\u20132746. doi:https:\/\/doi.org\/10.1016\/j.jacc.2021.02.038.","DOI":"10.1016\/j.jacc.2021.02.038"},{"issue":"47","key":"10.1016\/j.carrev.2025.02.005_bb0080","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1093\/eurheartj\/ehw033","article-title":"Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg?","volume":"37","author":"Galat","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2025.02.005_bb0085","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005066","article-title":"Occult transthyretin cardiac amyloid in severe calcific aortic stenosis: prevalence and prognosis in patients undergoing surgical aortic valve replacement","author":"Treibel","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.carrev.2025.02.005_bb0090","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jtcvs.2017.12.048","article-title":"Aortic valve replacement in patients with amyloidosis","volume":"156","author":"Java","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.carrev.2025.02.005_bb0095","doi-asserted-by":"crossref","unstructured":"Chacko L, Martone R, Bandera F, et al. Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis. Eur Heart J. Apr 07 2020;41(14):1439\u20131447. doi:https:\/\/doi.org\/10.1093\/eurheartj\/ehz905.","DOI":"10.1093\/eurheartj\/ehz905"},{"key":"10.1016\/j.carrev.2025.02.005_bb0100","article-title":"Cardiac amyloidosis in patients undergoing aortic valve replacement for aortic stenosis","volume":"41(Supplement_2):ehaa946.0273","author":"Fukuzawa","year":"2020","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.carrev.2025.02.005_bb0105","first-page":"283","article-title":"Prevalence and prognostic impact of apical sparing contractility pattern in patients with aortic stenosis referred for transcatheter aortic valve implantation","volume":"11","author":"Ferreira","year":"2021","journal-title":"Am J Cardiovasc Dis"},{"issue":"4","key":"10.1016\/j.carrev.2025.02.005_bb0110","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaccao.2021.08.008","article-title":"Concomitant transthyretin amyloidosis and severe aortic stenosis in elderly Indian population: a pilot study","volume":"3","author":"Singal","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"3","key":"10.1016\/j.carrev.2025.02.005_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jscai.2022.100188","article-title":"C-36 | in-hospital outcomes post-TAVR in patients with amyloidosis \u2013 a perspective from national inpatient sample","volume":"1","author":"Inestroza","year":"2022","journal-title":"Journal of the Society for Cardiovascular Angiography & Interventions"},{"key":"10.1016\/j.carrev.2025.02.005_bb0120","article-title":"Transcatheter aortic valve replacement in patients with aortic stenosis and cardiac amyloidosis","volume":"40","author":"Khawaja","year":"2022","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"16","key":"10.1016\/j.carrev.2025.02.005_bb0125","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030271","article-title":"Amyloid transthyretin cardiomyopathy in elderly patients with aortic stenosis undergoing Transcatheter aortic valve implantation","volume":"12","author":"Dobner","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.carrev.2025.02.005_bb0130","doi-asserted-by":"crossref","unstructured":"Elzeneini M, Gupta S, Assaf Y, et al. Outcomes of Transcatheter aortic valve replacement in patients with Coexisiting amyloidosis. JACC: Advances. 2023\/03\/01 2023;vol. 2(2):100255. doi:https:\/\/doi.org\/10.1016\/j.jacadv.2023.100255.","DOI":"10.1016\/j.jacadv.2023.100255"},{"issue":"4","key":"10.1016\/j.carrev.2025.02.005_bb0135","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.hlc.2023.09.019","article-title":"Clinical outcomes of aortic stenosis in amyloidosis: a United States National Cohort Study","volume":"33","author":"Mir","year":"2024","journal-title":"Heart Lung Circ"},{"issue":"19","key":"10.1016\/j.carrev.2025.02.005_bb0140","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2012.06.051","article-title":"Low-flow, low-gradient aortic stenosis with normal and depressed left ventricular ejection fraction","volume":"60","author":"Pibarot","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2025.02.005_bb0145","doi-asserted-by":"crossref","unstructured":"Clavel MA, Berthelot-Richer M, Le Ven F, et al. Impact of classic and paradoxical low flow on survival after aortic valve replacement for severe aortic stenosis. J Am Coll Cardiol. Feb 24 2015;65(7):645\u201353. doi:https:\/\/doi.org\/10.1016\/j.jacc.2014.11.047.","DOI":"10.1016\/j.jacc.2014.11.047"},{"issue":"5","key":"10.1016\/j.carrev.2025.02.005_bb0150","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1161\/CIR.0000000000000923","article-title":"ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2020","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.carrev.2025.02.005_bb0155","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2021","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.carrev.2025.02.005_bb0160","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2025.02.005_bb0165","doi-asserted-by":"crossref","unstructured":"Ahmad Y, Howard JP, Arnold AD, et al. Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trials. Eur Heart J. Mar 07 2023;44(10):836\u2013852. doi:https:\/\/doi.org\/10.1093\/eurheartj\/ehac642.","DOI":"10.1093\/eurheartj\/ehac642"},{"key":"10.1016\/j.carrev.2025.02.005_bb0170","doi-asserted-by":"crossref","unstructured":"Deeb GM, Reardon MJ, Chetcuti S, et al. 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. Jun 07 2016;67(22):2565\u201374. doi:https:\/\/doi.org\/10.1016\/j.jacc.2016.03.506.","DOI":"10.1016\/j.jacc.2016.03.506"},{"key":"10.1016\/j.carrev.2025.02.005_bb0175","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.carrev.2022.04.027","article-title":"Clinical outcome of TAVR vs. SAVR in patients with cardiac amyloidosis","volume":"43","author":"Khan","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"issue":"6","key":"10.1016\/j.carrev.2025.02.005_bb0180","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.008105","article-title":"Prevalence and prognostic significance of frailty among patients with transthyretin amyloidosis cardiomyopathy","volume":"14","author":"Fine","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.carrev.2025.02.005_bb0185","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.hjc.2021.11.001","article-title":"Prevalence and outcomes of concomitant cardiac amyloidosis and aortic stenosis: a systematic review and meta-analysis","volume":"64","author":"Ho","year":"2022","journal-title":"Hellenic J Cardiol"},{"issue":"7","key":"10.1016\/j.carrev.2025.02.005_bb0190","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014115","article-title":"Reverse remodeling following valve replacement in coexisting aortic stenosis and transthyretin cardiac amyloidosis","volume":"15","author":"Nitsche","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2025.02.005_bb0195","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.carrev.2023.07.002","article-title":"Outcomes of transcatheter aortic valve replacement in patients with and without amyloidosis: a nationwide analysis from the United States","volume":"58","author":"Ismayl","year":"2024","journal-title":"Cardiovasc Revasc Med"},{"issue":"5","key":"10.1016\/j.carrev.2025.02.005_bb0200","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1002\/ehf2.13876","article-title":"Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta-analysis","volume":"9","author":"Cannata","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.carrev.2025.02.005_bb0205","doi-asserted-by":"crossref","unstructured":"Beuthner BE, Elkenani M, Evert K, et al. Histological assessment of cardiac amyloidosis in patients undergoing transcatheter aortic valve replacement. ESC Heart Fail. Feb 26 2024;doi:https:\/\/doi.org\/10.1002\/ehf2.14709.","DOI":"10.1002\/ehf2.14709"},{"issue":"9","key":"10.1016\/j.carrev.2025.02.005_bb0210","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/ckj\/sfac118","article-title":"Kidney involvement in hereditary transthyretin amyloidosis: a cohort study of 103 patients","volume":"15","author":"Solignac","year":"2022","journal-title":"Clin Kidney J"},{"issue":"1","key":"10.1016\/j.carrev.2025.02.005_bb0215","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000529729","article-title":"Transcatheter aortic valve replacement-associated acute kidney injury: an update","volume":"13","author":"Rivera","year":"2023","journal-title":"Cardiorenal Med"},{"issue":"38","key":"10.1016\/j.carrev.2025.02.005_bb0220","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Casta\u00f1o","year":"2017","journal-title":"Eur Heart J"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925000478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925000478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T04:44:36Z","timestamp":1746074676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838925000478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":44,"alternative-id":["S1553838925000478"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2025.02.005","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of aortic stenosis in patients with cardiac amyloidosis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2025.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}